Cerevel Therapeutics Holdings, Inc. 2021 Q1 - Results - Earnings Call Presentation Published 17 May 2021 Full Article
NA Proactive news snapshot: Kintara Therapeutics, PlantX Life, Binovi Technologies, Atlas Engineered Products, ImagineAR UPDATE ... Proactive Investors 19 May 2021 Analysts at Aegis Capital Corp rated Kintara Therapeutics Inc (NASDAQ:KTRA) a 'Buy,' while maintaining a $7 share target price on..